183 related articles for article (PubMed ID: 32392873)
1. New Insights into Key Determinants for Adenosine 1 Receptor Antagonists Selectivity Using Supervised Molecular Dynamics Simulations.
Bolcato G; Bissaro M; Deganutti G; Sturlese M; Moro S
Biomolecules; 2020 May; 10(5):. PubMed ID: 32392873
[TBL] [Abstract][Full Text] [Related]
2. A Taxicab geometry quantification system to evaluate the performance of in silico methods: a case study on adenosine receptors ligands.
Kuder KJ; Michalik I; Kieć-Kononowicz K; Kolb P
J Comput Aided Mol Des; 2020 Jun; 34(6):697-707. PubMed ID: 32112287
[TBL] [Abstract][Full Text] [Related]
3. Structural Basis for Binding of Allosteric Drug Leads in the Adenosine A
Miao Y; Bhattarai A; Nguyen ATN; Christopoulos A; May LT
Sci Rep; 2018 Nov; 8(1):16836. PubMed ID: 30442899
[TBL] [Abstract][Full Text] [Related]
4. Identification of new potent A
Wei Y; Wang M; Li Y; Hong Z; Li D; Lin J
Eur J Med Chem; 2020 Feb; 187():111936. PubMed ID: 31855793
[TBL] [Abstract][Full Text] [Related]
5. Fragment-Based Discovery of Subtype-Selective Adenosine Receptor Ligands from Homology Models.
Ranganathan A; Stoddart LA; Hill SJ; Carlsson J
J Med Chem; 2015 Dec; 58(24):9578-90. PubMed ID: 26592528
[TBL] [Abstract][Full Text] [Related]
6. Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A
Val C; Rodríguez-García C; Prieto-Díaz R; Crespo A; Azuaje J; Carbajales C; Majellaro M; Díaz-Holguín A; Brea JM; Loza MI; Gioé-Gallo C; Contino M; Stefanachi A; García-Mera X; Estévez JC; Gutiérrez-de-Terán H; Sotelo E
J Med Chem; 2022 Feb; 65(3):2091-2106. PubMed ID: 35068155
[TBL] [Abstract][Full Text] [Related]
7. The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A
Squarcialupi L; Betti M; Catarzi D; Varano F; Falsini M; Ravani A; Pasquini S; Vincenzi F; Salmaso V; Sturlese M; Varani K; Moro S; Colotta V
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):248-263. PubMed ID: 28114825
[TBL] [Abstract][Full Text] [Related]
8. Role of the Second Extracellular Loop of the Adenosine A1 Receptor on Allosteric Modulator Binding, Signaling, and Cooperativity.
Nguyen AT; Vecchio EA; Thomas T; Nguyen TD; Aurelio L; Scammells PJ; White PJ; Sexton PM; Gregory KJ; May LT; Christopoulos A
Mol Pharmacol; 2016 Dec; 90(6):715-725. PubMed ID: 27683013
[TBL] [Abstract][Full Text] [Related]
9. Extracellular Loop 2 of the Adenosine A1 Receptor Has a Key Role in Orthosteric Ligand Affinity and Agonist Efficacy.
Nguyen AT; Baltos JA; Thomas T; Nguyen TD; Muñoz LL; Gregory KJ; White PJ; Sexton PM; Christopoulos A; May LT
Mol Pharmacol; 2016 Dec; 90(6):703-714. PubMed ID: 27683014
[TBL] [Abstract][Full Text] [Related]
10. Structures of Human A
Cheng RKY; Segala E; Robertson N; Deflorian F; Doré AS; Errey JC; Fiez-Vandal C; Marshall FH; Cooke RM
Structure; 2017 Aug; 25(8):1275-1285.e4. PubMed ID: 28712806
[TBL] [Abstract][Full Text] [Related]
11. Structure of the Adenosine A
Glukhova A; Thal DM; Nguyen AT; Vecchio EA; Jörg M; Scammells PJ; May LT; Sexton PM; Christopoulos A
Cell; 2017 Feb; 168(5):867-877.e13. PubMed ID: 28235198
[TBL] [Abstract][Full Text] [Related]
12. Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A(1) adenosine receptor ligands.
Giovannoni MP; Vergelli C; Cilibrizzi A; Crocetti L; Biancalani C; Graziano A; Dal Piaz V; Loza MI; Cadavid MI; Díaz JL; Gavaldà A
Bioorg Med Chem; 2010 Nov; 18(22):7890-9. PubMed ID: 20937560
[TBL] [Abstract][Full Text] [Related]
13. Derivatives of benzimidazol-2-ylquinoline and benzimidazol-2-ylisoquinoline as selective A1 adenosine receptor antagonists with stimulant activity on human colon motility.
Cosimelli B; Taliani S; Greco G; Novellino E; Sala A; Severi E; Da Settimo F; La Motta C; Pugliesi I; Antonioli L; Fornai M; Colucci R; Blandizzi C; Daniele S; Trincavelli ML; Martini C
ChemMedChem; 2011 Oct; 6(10):1909-18. PubMed ID: 21796795
[TBL] [Abstract][Full Text] [Related]
14. 8-Benzylaminoxanthine scaffold variations for selective ligands acting on adenosine A
Załuski M; Schabikowski J; Jaśko P; Bryła A; Olejarz-Maciej A; Kaleta M; Głuch-Lutwin M; Brockmann A; Hinz S; Zygmunt M; Kuder K; Latacz G; Vielmuth C; Müller CE; Kieć-Kononowicz K
Bioorg Chem; 2020 Aug; 101():104033. PubMed ID: 32629282
[TBL] [Abstract][Full Text] [Related]
15. Carbamate substituted 2-amino-4,6-diphenylpyrimidines as adenosine receptor antagonists.
Robinson SJ; Petzer JP; Rousseau AL; Terre'Blanche G; Petzer A; Lourens ACU
Bioorg Med Chem Lett; 2016 Feb; 26(3):734-738. PubMed ID: 26776359
[TBL] [Abstract][Full Text] [Related]
16. Structure-Based Design, Synthesis, and In Vivo Antinociceptive Effects of Selective A
Petrelli R; Scortichini M; Belardo C; Boccella S; Luongo L; Capone F; Kachler S; Vita P; Del Bello F; Maione S; Lavecchia A; Klotz KN; Cappellacci L
J Med Chem; 2018 Jan; 61(1):305-318. PubMed ID: 29257884
[TBL] [Abstract][Full Text] [Related]
17. Targeting adenosine receptors with coumarins: synthesis and binding activities of amide and carbamate derivatives.
Matos MJ; Gaspar A; Kachler S; Klotz KN; Borges F; Santana L; Uriarte E
J Pharm Pharmacol; 2013 Jan; 65(1):30-4. PubMed ID: 23215685
[TBL] [Abstract][Full Text] [Related]
18. 7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: structural investigations at the 5-position to target human A₁ and A(2A) adenosine receptors. Molecular modeling and pharmacological studies.
Squarcialupi L; Colotta V; Catarzi D; Varano F; Betti M; Varani K; Vincenzi F; Borea PA; Porta N; Ciancetta A; Moro S
Eur J Med Chem; 2014 Sep; 84():614-27. PubMed ID: 25063944
[TBL] [Abstract][Full Text] [Related]
19. New potent and selective A
Lambertucci C; Marucci G; Dal Ben D; Buccioni M; Spinaci A; Kachler S; Klotz KN; Volpini R
Eur J Med Chem; 2018 May; 151():199-213. PubMed ID: 29614417
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of 2-benzylidene-1-tetralone derivatives as antagonists of A
Legoabe LJ; Van der Walt MM; Terre'Blanche G
Chem Biol Drug Des; 2018 Jan; 91(1):234-244. PubMed ID: 28734058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
